Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial

被引：0

作者：

Shahin Akhondzadeh

Raofeh Ghayyoumi

Farzin Rezaei

Bahman Salehi

Amir-Hossein Modabbernia

Azad Maroufi

Gholam-Reza Esfandiari

Mehrangiz Naderi

Fariba Ghebleh

Mina Tabrizi

Shams-Ali Rezazadeh

机构：

[1] Tehran University of Medical Sciences,Psychiatric Research Center, Roozbeh Psychiatric Hospital

[2] Kurdistan University of Medical Sciences,Qods Hospital

[3] Arak University of Medical Sciences,Shaheed Hashemi Senejani Hospital

[4] Tehran University of Medical Sciences,Department of Medical Genetics, Faculty of Medicine

[5] Institute of Medicinal Plants (ACECR),undefined

来源：

Psychopharmacology | 2011年 / 213卷

关键词：

Adjunctive therapy; Sildenafil; Negative symptoms; Schizophrenia;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：809 / 815

页数：6

共 50 条

[31] Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial
Akhondzadeh, S
Nejatisafa, AA
Amini, H
Mohammadi, MR
Larijani, B
Kashani, L
Raisi, F
Kamalipour, A
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (06): : 1007 - 1012
[32] Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial
Usall, Judith
Huerta-Ramos, Elena
Iniesta, Raquel
Cobo, Jesus
Araya, Susana
Roca, Mercedes
Serrano-Blanco, Antoni
Teba, Fernando
Ochoa, Susana
JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (11) : 1552 - 1557
[33] Primary negative symptoms in schizophrenia:: Treatment with paroxetine in a double-blind placebo-controlled trial
Jockers-Scherübl, MC
Godemann, F
Bauer, A
Wolfensteller, U
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S325 - S325
[34] Effects of memantine added to risperidone on the symptoms of schizophrenia: A randomized double-blind, placebo-controlled clinical trial
Mazinani, Robabeh
Nejati, Somayeh
Khodaei, Mohammadreza
PSYCHIATRY RESEARCH, 2017, 247 : 291 - 295
[35] Adjunctive armodafinil for negative symptoms in adults with schizophrenia: A double-blind, placebo-controlled study
Kane, John M.
Yang, Ronghua
Youakim, James M.
SCHIZOPHRENIA RESEARCH, 2012, 135 (1-3) : 116 - 122
[36] ADJUNCTIVE ARMODAFINIL FOR NEGATIVE SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA: A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Kane, John M.
Youakim, J. M.
Yang, R.
Tiller, J.
SCHIZOPHRENIA BULLETIN, 2011, 37 : 307 - 308
[37] Adjunctive Memantine Treatment of Schizophrenia A Double-Blind, Randomized Placebo-Controlled Study
Hassanpour, Fatemeh
Zarghami, Mehran
Mouodi, Sussan
Moosazadeh, Mahmood
Barzegar, Fatemeh
Bagheri, Maedeh
Hendouei, Narjes
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (06) : 634 - 638
[38] Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial
Samaei, Areoo
Moradi, Kamyar
Bagheri, Sayna
Ashraf-Ganjouei, Amir
Alikhani, Rosa
Mousavi, Seiedeh Bentolhoda
Rezaei, Farzin
Akhondzadeh, Shahin
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2020, 23 (12): : 775 - 782
[39] Citicoline (CDP-choline) add-on therapy to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial
Ghajar, Alireza
Gholamian, Faezeh
Tabatabei-Motlagh, Maryam
Afarideh, Mohsen
Rezaei, Farzin
Ghazizadeh-Hashemi, Maryam
Akhondzadeh, Shahin
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2018, 33 (04)
[40] L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial
Ghajar, Alireza
Khoaie-Ardakani, Mohammad-Reza
Shahmoradi, Zahara
Alavi, Amir-Reza
Afarideh, Mohsen
Shalbafan, Mohammad-Reza
Ghazizadeh-Hashemi, Maryam
Akhondzadeh, Shahin
PSYCHIATRY RESEARCH, 2018, 262 : 94 - 101

← 1 2 3 4 5 →